Business Description
Jubilant Pharmova Ltd
ISIN : INE700A01033
Total Employee Number:
5,547Compare
Compare
Traded in other countries / regions
530019.India IPO Date
1995-05-05Description
Jubilant Pharmova Ltd is an integrated pharmaceutical company. The company operates in the following segments; Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation; and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment which specializes in developing, manufacturing, commercializing, and distributing therapeutic agents in the nuclear medicine domain. Geographically, it derives a majority of its revenue from the Americas and Europe and the rest from India and the Rest of the world.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.51 | |||||
Debt-to-EBITDA | 2.86 | |||||
Interest Coverage | 3.87 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.91 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.8 | |||||
3-Year EBITDA Growth Rate | 19.1 | |||||
3-Year FCF Growth Rate | -13.1 | |||||
3-Year Book Growth Rate | 9.7 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 24.58 | |||||
9-Day RSI | 32.73 | |||||
14-Day RSI | 38.08 | |||||
3-1 Month Momentum % | 4.86 | |||||
6-1 Month Momentum % | -0.92 | |||||
12-1 Month Momentum % | -18.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.62 | |||||
Quick Ratio | 1.13 | |||||
Cash Ratio | 0.59 | |||||
Days Inventory | 165.14 | |||||
Days Sales Outstanding | 43.22 | |||||
Days Payable | 149.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.53 | |||||
Dividend Payout Ratio | 0.18 | |||||
Forward Dividend Yield % | 0.53 | |||||
5-Year Yield-on-Cost % | 0.52 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -1.61 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.85 | |||||
Operating Margin % | 9.96 | |||||
Net Margin % | 4.85 | |||||
EBITDA Margin % | 15.4 | |||||
FCF Margin % | -2.7 | |||||
OCF Margin % | 14.92 | |||||
ROE % | 6 | |||||
ROA % | 2.86 | |||||
ROIC % | 4.61 | |||||
ROC (Joel Greenblatt) % | 12.59 | |||||
ROCE % | 7.08 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 37.93 | |||||
Forward PE Ratio | 29.33 | |||||
PE Ratio without NRI | 34.41 | |||||
Shiller PE Ratio | 22.53 | |||||
Price-to-Owner-Earnings | 46.15 | |||||
PEG Ratio | 49.16 | |||||
PS Ratio | 1.84 | |||||
PB Ratio | 2.13 | |||||
Price-to-Tangible-Book | 4.95 | |||||
Price-to-Operating-Cash-Flow | 12.31 | |||||
EV-to-EBIT | 20.5 | |||||
EV-to-EBITDA | 13.38 | |||||
EV-to-Revenue | 2.06 | |||||
EV-to-FCF | -78.13 | |||||
Price-to-GF-Value | 0.87 | |||||
Price-to-Projected-FCF | 1.74 | |||||
Price-to-Median-PS-Value | 1.34 | |||||
Price-to-Graham-Number | 2.73 | |||||
Earnings Yield (Greenblatt) % | 4.88 | |||||
FCF Yield % | -1.51 | |||||
Forward Rate of Return (Yacktman) % | 1.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jubilant Pharmova Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 82,250 | ||
| EPS (TTM) (₹) | 25.08 | ||
| Beta | 1.1853 | ||
| 3-Year Sharpe Ratio | 0.75 | ||
| 3-Year Sortino Ratio | 1.56 | ||
| Volatility % | 27.9 | ||
| 14-Day RSI | 38.08 | ||
| 14-Day ATR (₹) | 26.71098 | ||
| 20-Day SMA (₹) | 982.035 | ||
| 12-1 Month Momentum % | -18.55 | ||
| 52-Week Range (₹) | 783.75 - 1183.9 | ||
| Shares Outstanding (Mil) | 158.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jubilant Pharmova Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jubilant Pharmova Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2027 | 2026-10-30 | In 89 days | ||
| General meeting for 2026 | 2026-08-28 11:00 | In 27 days | ||
| First quarter earnings results for 2027 | 2026-08-28 | In 26 days | ||
| Annual report for 2026 | 2026-08-05 | In 3 days | ||
| INR 5.000000 Cash Dividend | 2026-07-24 | 970.85 (-1.95%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-22 18:00 | 1,011.25 (-1.71%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-22 | 1,011.25 (-1.71%) | ||
| Third quarter earnings results for 2026 | 2026-02-06 | 974.50 (-0.49%) | ||
| Second quarter earnings results for 2026 | 2025-10-31 | 1,119.60 (-1.80%) | ||
| General meeting for 2025 | 2025-08-29 11:00 | 1,039.30 (+0.38%) |
Show
Entries
Jubilant Pharmova Ltd Frequently Asked Questions
What is Jubilant Pharmova Ltd(BOM:530019)'s stock price today?
The current price of BOM:530019 is ₹934.80. The 52 week high of BOM:530019 is ₹1183.90 and 52 week low is ₹783.75.
When is next earnings date of Jubilant Pharmova Ltd(BOM:530019)?
The next earnings date of Jubilant Pharmova Ltd(BOM:530019) is 2026-08-28 Est..
Does Jubilant Pharmova Ltd(BOM:530019) pay dividends? If so, how much?
The Dividend Yield %  of Jubilant Pharmova Ltd(BOM:530019) is 0.53% (As of Today), Highest Dividend Payout Ratio of Jubilant Pharmova Ltd(BOM:530019) was 0.41. The lowest was 0.06. And the median was 0.17. The  Forward Dividend Yield % of Jubilant Pharmova Ltd(BOM:530019) is 0.53%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Jubilant Pharmova Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers